Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004623 (
bacterial infection
)
15,226
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Employing the expression cloning technique, we cloned a novel scavenger receptor that is structurally unrelated to other scavenger receptors. The cloned receptor contained fasciclin (Fas-1), epidermal growth factor (EGF)-like, laminin-type EGF-like, and link domains. Based on the domain structures, we temporarily named it
FEEL-1
(fasciclin, EGF-like, laminin-type EGF-like, and link domain-containing scavenger receptor-1). A data base search suggested the presence of a paralogous gene of
FEEL-1
, the full-length cDNA of this gene was also cloned, and its nucleotide sequence was determined. The deduced amino acid sequence of the clone indicated that its domain organization is similar to
FEEL-1
, and we named this clone FEEL-2. The effect of monoclonal antibodies against
FEEL-1
indicated that
FEEL-1
is the major receptor for 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbo-cyanine perchlorate (DiI)-labeled acetylated low density lipoprotein (DiI-Ac-LDL) in human umbilical vein endothelial cells. Reverse transcription and PCR analysis revealed that both
FEEL-1
and FEEL-2 were expressed in several tissues and expressed highly in the spleen and lymph node. On the other hand, only
FEEL-1
was expressed in mononuclear cells, particularly resting CD14(+) cells. The transient expression of
FEEL-1
and FEEL-2 in Chinese hamster ovary cells demonstrated that both FEELs could bind to DiI-Ac-LDL. Both receptors were also found to bind to Gram-negative and Gram-positive bacteria. These results suggest that FEELs play important roles in the defense mechanisms against
bacterial infection
. Finally, the phenotypic effect of the inhibition of
FEEL-1
on vascular remodeling was tested in vitro using the Matrigel tube formation assay, and we found a marked reduction in the degree of cell-cell interaction in anti-
FEEL-1
monoclonal antibody-treated cells, suggesting the role of this receptor in angiogenesis.
...
PMID:FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities. 1207 38
The scavenger receptor
FEEL-1
/stabilin-1 is known as the marker of alternatively activated macrophage and sinusoidal endothelial cell.
FEEL-1
/stabilin-1 is a multifunctional transmembrane glycoprotein that is implicated in
bacterial infection
, diabetes, atherosclerosis, wound healing, and innate immunity. In the current study, we have identified the phox-homology domain containing protein SNX17 as a novel interaction partner of
FEEL-1
/stabilin-1 in endothelial cells. SNX17 directly interacts with
FEEL-1
/stabilin-1 and regulates its trafficking. Studies using the cytoplasmic domain of truncated or mutant
FEEL-1
/stabilin-1 suggest that the NPxF motif of the
FEEL-1
/stabilin-1 cytoplasmic tail is required for its interaction with SNX17. By transfecting cells with small interfering RNA targeting SNX17, total cellular
FEEL-1
/stabilin-1 expression and
FEEL-1
/stabilin-1-mediated ligand uptake were significantly decreased due to the enhancement of
FEEL-1
/stabilin-1 protein degradation. Our results identify SNX17 as a novel interaction partner of
FEEL-1
/stabilin-1 in endothelial cells.
...
PMID:Adaptor protein sorting nexin 17 interacts with the scavenger receptor FEEL-1/stabilin-1 and modulates its expression on the cell surface. 2022 21